Advancements in Hematologic Malignancies: Innovations in Diagnosis and Therapy
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 45
Special Issue Editor
Interests: hematologic malignancies; stem cell transplantation; immunotherapy; CAR-T cell therapy; multiple myeloma; leukemia and lymphoma; precision medicine; novel therapeutics; hematopoietic stem cells; drug resistance in cancer
Special Issue Information
Dear Colleagues,
We are pleased to announce the upcoming Special Issue on “Advancements in Hematologic Malignancies: Innovations in Diagnosis and Therapy” in Life. Hematologic malignancies, including leukemia, lymphoma, and multiple myeloma, remain significant challenges in medical research and clinical practice. However, recent innovations in molecular diagnostics, immunotherapy, and stem cell transplantation have provided new opportunities for improving patient outcomes. This Special Issue aims to highlight the latest advancements in the diagnosis, treatment, and management of hematologic cancers, including novel therapeutic approaches, precision medicine, and the use of emerging technologies such as CAR-T cell therapy. We welcome submissions from researchers and clinicians involved in the exploration of cutting-edge therapies, biomarkers for early detection, and strategies to overcome drug resistance in hematologic malignancies.
We would like to invite you to contribute your latest research findings and reviews to this Special Issue, which will serve as a platform to advance the knowledge and understanding of hematologic malignancies. We look forward to receiving your contributions.
Dr. Chohao Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematologic malignancies
- stem cell transplantation
- CAR-T cell therapy
- immunotherapy
- multiple myeloma
- leukemia
- precision medicine
- hematopoietic stem cells
- drug resistance
- novel therapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
